Revenue cycle · AI RCM + desktop PA assistant
Enter Health
Enter Health provides an AI revenue-cycle platform from eligibility through posting, plus CTRL ENTER desktop assistance for prior auth and coding questions. It is not a standalone payer UM console.
Strong fit
- Mid-market specialty groups that want AI across eligibility, claims, posting, and denial queues
- Teams that also need a desktop assistant (CTRL ENTER) for prior-auth packets and coding questions
- Buyers measuring clean-claim rate, cash gap, and underpayment recovery rather than portal vanity metrics
Weak fit
- Enterprises standardized on a single mega-RCM outsourcing contract with no appetite for a parallel engine
- Clinics shopping only a consumer telehealth brand or an ambulatory EHR replacement
- Buyers who will not give API or clearinghouse access the product needs
Bottom line
Enter Health earns a Recommend for mid-market specialty practices that want an AI revenue-cycle engine plus a desktop assistant for prior-auth and coding questions. Outcomes show up in higher contract-value collection and shorter cash gaps when ENTER owns eligibility through posting and CTRL ENTER sits on staff desktops. Product strength is end-to-end RCM automation with PA assistance rather than a pure PA network like Careviso. Implementation needs RCM ownership and interface work. Pricing is quote-based. Third-party signals cluster near roughly $6M revenue and a small team, under the hard cap. Score sits near Collectly and MDaudit on overall for a broader AI RCM shape, above PatientPay and Rivia on automation depth.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Enter Health (enter.health) automates revenue cycle work from EMR through payment posting and layers CTRL ENTER, a HIPAA-oriented desktop assistant, for prior-auth packets, coding questions, and staff Q&A on top of existing tools. CEO Jordan Kelley leads the company with co-founder roots in healthcare payments.
It is broader than a prior-auth point tool. Compare Collectly or PatientPay when patient billing is the only pain, Aptarro when mid-market AI RCM is the shortlist frame, and Careviso when lab PA networks matter more than full RCM.
Score reflects strong automation outcomes with middling price clarity until quotes are on paper.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Enter Health | 7.3 | 7.0 |
| Collectly | 7.4 | 7.2 |
| PatientPay | 7.0 | 7.0 |
| Aptarro | 7.0 | 6.8 |
| MDaudit | 7.4 | 7.1 |
| Nym | 6.6 | 6.4 |
| Rivia Health | 6.5 | 6.4 |
Pricing
| Item | Detail |
|---|---|
| Model | AI RCM platform and CTRL ENTER desktop assistant packaging; quote-based. |
| What usually drives cost | Claim volume, modules (RCM engine vs assistant), clearinghouse connectivity, and support. |
| What to ask in diligence | All-in monthly or percent-of-collections economics at your claim volume, with PA assistant seats defined. |
| Published pricing | Public list price: not published. Expect platform plus usage packaging. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Enter Health to function | |
| RCM owner with authority to change edit and billing workflows | Software without owners becomes shelfware. |
| Baseline clean-claim, denial, or cash-gap metrics captured | You cannot prove value without a before number. |
| PM/EHR interface path and test claims ready | Orphan edits create more rework. |
| Staffing plan for work queues after go-live | Unowned queues age into write-offs. |
| Payer mix and top denial reasons documented | Generic rules miss your real leaks. |
| What will maximize your value | |
| Track clean-claim rate or cash gap weekly for 90 days | Feature tours are not outcomes. |
| Tune the top denial reasons in month one | Boiling the ocean delays cash. |
| Turn off redundant manual workarounds after parallel week | Dual paths erase the gain. |
| Review aged work-queue items in a standing huddle | Silent aging hides failure. |
| Publish a monthly cash and denial digest to finance leaders | Hidden leakage surprises the CFO. |
| Deal-breakers | |
| Nobody will own edit or billing queues. | |
| You refuse PM/EHR interface work the product needs. | |
| You expect an EHR replacement from an RCM tool. | |
| Leadership will not measure cash or denial outcomes. | |
| Compliance blocks the patient-communication path you require. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Scope & baseline | 2-4 weeks - Metrics, interfaces, rule scope. |
| 2 | Configure | 4-10 weeks - Rules, templates, PM hooks; test claims. |
| 3 | Pilot | 2-6 weeks - One specialty or site; queue owners. |
| 4 | Scale | 1-3 months - Expand payers; retire shadow processes. |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category actually buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.